New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients

Pokaži ostale verzije (1)

Two-dimensional gel electrophoresis (2-DE) is often used to separate plasma or serum proteins in an attempt to identify novel disease biomarkers. A major problem with this approach is the presence of high abundant plasma/serum proteins which limit the detection of low abundance features. We used two...

Bibliografski detalji
Glavni autori:	Gangadharan, B, Antrobus, R, Bapat, M, Rossa, J, Kumar, A, Chittenden, D, Kampa, B, Barnes, E, Klenerman, P, Dwek, R, Zitzmann, N
Format:	Journal article
Izdano:	OMICS International 2014

Slični predmeti

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
od: Gangadharan, B, i dr.
Izdano: (2016)

Discovery of new liver fibrosis markers in hepatitis C patients using proteomics
od: Gangadharan, B, i dr.
Izdano: (2011)

New proteomics approaches for discovering biomarkers: Searching for liver fibrosis markers in hepatitis c patients
od: Gangadharan, B, i dr.
Izdano: (2012)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
od: Gangadharan, B, i dr.
Izdano: (2011)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
od: Gangadharan, B, i dr.
Izdano: (2011)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients using proteomics
od: Gangadharan, B, i dr.
Izdano: (2014)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study
od: Gangadharan, B, i dr.
Izdano: (2012)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.
od: Bevin Gangadharan, i dr.
Izdano: (2012-01-01)

Novel serum biomarker candidates for liver fibrosis in hepatitis C patients
od: Gangadharan, B, i dr.
Izdano: (2007)

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers
od: Gangadharan, B, i dr.
Izdano: (2016)

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers
od: Gangadharan, B, i dr.
Izdano: (2016)

PTH-092 Discovery and quantitation of novel liver fibrosis biomarkers using proteomics
od: Gangadharan, B, i dr.
Izdano: (2015)

Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker
od: Gangadharan, B, i dr.
Izdano: (2012)

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
od: Gangadharan, B, i dr.
Izdano: (2008)

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
od: Gangadharan, B, i dr.
Izdano: (2010)

Proteomic analysis of HepaRG cells: a novel cell line that supports hepatitis B virus infection.
od: Narayan, R, i dr.
Izdano: (2009)

LC-MS based discovery of novel protein biomarkers and their quantitation in HCV fibrosis and NASH diseased human serum
od: Kumar, A, i dr.
Izdano: (2014)

Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome.
od: Antrobus, R, i dr.
Izdano: (2009)

Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro.
od: Woodhouse, S, i dr.
Izdano: (2010)

Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery.
od: Pardo, M, i dr.
Izdano: (2007)

Discovery and quantitation of novel liver fibrosis biomarkers in hepatitis C patients
od: Gangadharan, B
Izdano: (2017)

Uptake and trafficking of liposomes to the endoplasmic reticulum
od: Pollock, S, i dr.
Izdano: (2010)

Differential proteome analysis of CRP-activated platelets
od: Garcia, A, i dr.
Izdano: (2005)

Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum.
od: Pardo, M, i dr.
Izdano: (2006)

A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter.
od: García, A, i dr.
Izdano: (2006)

Applying proteomics technology to platelet research.
od: García, A, i dr.
Izdano: (2005)

Glycobiology against viruses: Antiviral drug discovery
od: Zitzmann, N, i dr.
Izdano: (2006)

Towards the first antibody-free serum biomarker assay for NAFLD
od: Gangadharan, B, i dr.
Izdano: (2017)

Proteome deconvolution of liver biopsies reveals hepatic cell composition as an important marker of fibrosis
od: Niklas Handin, i dr.
Izdano: (2023-01-01)

Towards the first antibody-free serum biomarker assay for NAFLD
od: Gangadharan, B, i dr.
Izdano: (2017)

Discovery of tumor markers for gastric cancer by proteomics.
od: Jeng-Yih Wu, i dr.
Izdano: (2014-01-01)

Use of castanospermine and substituted-castonospermine compounds for treating hepatitis virus infections
od: Jacob, G, i dr.
Izdano: (2001)

Proteomics in viral disease
od: Gangadharan, B
Izdano: (2006)

Non-Invasive markers for hepatic fibrosis
od: Lal Priyanka, i dr.
Izdano: (2011-08-01)

Unraveling adaptive evolution: how a single point mutation affects the protein coregulation network.
od: Knight, C, i dr.
Izdano: (2012)

Two dimensional gel electrophoresis using narrow pH 3-5.6 immobilised pH gradient strips identifies potential novel disease biomarkers in plasma or serum
od: Gangadharan, B, i dr.
Izdano: (2011)

Protein-protein interactions: modeling the hepatitis C virus ion channel p7.
od: Patargias, G, i dr.
Izdano: (2005)

The Hepatitis C Virus E2p7 localization and topology in a recombinant system
od: Popescu, C, i dr.
Izdano: (2009)

Proteome analysis of human uveal melanoma cells by two-dimensional gel electrophoresis and mass spectrometry
od: Pardo, M, i dr.
Izdano: (2005)

Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
od: Pardo, M, i dr.
Izdano: (2005)